Literature DB >> 23495048

Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.

Seyed Ali Mousavi1, Marita Sporstøl Fønhus, Grete Mørk Kindberg, Helge Tolleshaug, Trond Berg.   

Abstract

Activated hepatic stellate cells (HSCs) play a central role during hepatic tissue repair through their influence on extracellular matrix remodelling. We have determined whether the activity levels of cathepsin B and D are affected by in vitro activation of rat HSCs, and whether the enzymes were released from the cells. Furthermore, given the important role of the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF-IIR) in the intracellular transport of lysosomal enzymes, we have examined whether changes in the activity of these proteases were associated with parallel changes in the level of the M6P/IGF-IIR. The activity of cathepsin B and D increased ∼4 times between 2 and 8 days of HSC culture. This result was supported by analysing mRNA expression by RT-PCR. The cells released the enzymes into the culture medium, amounting to ∼10% of the cell-associated activity over 24 h. The release of enzymes was not affected by reducing medium pH from 7.4 to 6.2, indicating that the enzymes were transported to the medium independently of the M6P/IGF-II-R. The released cathepsin B was mostly in the inactive proenzyme form. HSC activation led to a particularly large increase in M6P/IGF-IIR expression. A large proportion of the receptors was located on the cell surface and was found to be very suitable for measuring endocytosis of (125) I-IGF-II. The results show that the endocytic activity increased in parallel with the increase in surface receptors and activity of lysosomal enzymes. Degradation of the ligand was reduced by inhibitors of lysosomal proteases and therefore took place in lysosomes.
Copyright © 2013 International Federation for Cell Biology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23495048     DOI: 10.1002/cbin.10085

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  2 in total

1.  Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells.

Authors:  Zhen Zhao; Yuanke Li; Akshay Jain; Zhijin Chen; Hao Liu; Wei Jin; Kun Cheng
Journal:  Nanomedicine       Date:  2017-09-07       Impact factor: 5.307

2.  Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis.

Authors:  Zhijin Chen; Akshay Jain; Hao Liu; Zhen Zhao; Kun Cheng
Journal:  J Pharmacol Exp Ther       Date:  2019-03-18       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.